Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating (Q50543689)
Jump to navigation
Jump to search
scientific article published on 6 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating |
scientific article published on 6 March 2011 |
Statements
1 reference
Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating (English)
1 reference
1 reference
Paul Richardson
1 reference
Kenneth Anderson
1 reference
Tadeusz Robak
1 reference
Dixie-Lee Esseltine
1 reference
Helgi van de Velde
1 reference
Nuriet Khuageva
1 reference
Ofer Shpilberg
1 reference
Maria-Victoria Mateos
1 reference
Andrew Cakana
1 reference
Maria Teresa Petrucci
1 reference
William Deraedt
1 reference
Rudolf Schlag
1 reference
Martin Kropff
1 reference
Marie-Christiane Vekemans
1 reference
Viktor Rossiev
1 reference
Jian Hou
1 reference
Kevin Liu
1 reference
Jesús F San Miguel
1 reference
6 March 2011
1 reference
153
1 reference
2
1 reference
212-221
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference